Home >> Signaling Pathways >> GPCR/G protein

GPCR/G protein

Products for  GPCR/G protein

  1. Cat.No. Product Name Information
  2. GC38007 β-Melanocyte Stimulating Hormone (MSH), human TFA β-Melanocyte Stimulating Hormone (MSH), human TFA  Chemical Structure
  3. GC40105 βARK1 Inhibitor βARK1 inhibitor is an inhibitor of G protein-coupled receptor kinase 2/β-adrenergic receptor kinase 1 (GRK2/βARK1; IC50 = 126 μM). βARK1 Inhibitor  Chemical Structure
  4. GC61462 γ-1-Melanocyte Stimulating Hormone (MSH), amide γ-1-Melanocyte Stimulating Hormone (MSH), amide  Chemical Structure
  5. GC17002 γ1-MSH melanocortin MC3 receptor agonist γ1-MSH  Chemical Structure
  6. GC62708 σ1 Receptor antagonist-1 σ1 Receptor antagonist-1  Chemical Structure
  7. GC15519 α-CGRP (human)

    Endogenous calcitonin gene-related peptide receptor (CGRP) agonist

    α-CGRP (human)  Chemical Structure
  8. GC11346 α-helical CRF 9-41 Antagonist of corticotropin releasing factor receptor α-helical CRF 9-41  Chemical Structure
  9. GC11577 α-Methyl-5-hydroxytryptamine maleate 5-HT2B receptor agonist α-Methyl-5-hydroxytryptamine maleate  Chemical Structure
  10. GC31237 α1 adrenoceptor-MO-1 α1 adrenoceptor-MO-1  Chemical Structure
  11. GC33681 β-Caryophyllene ((−)-trans-Caryophyllene) β-Caryophyllene ((−)-trans-Caryophyllene)  Chemical Structure
  12. GC33693 β-Melanocyte Stimulating Hormone (MSH), human (Beta-MSH (1-22) (human)) β-Melanocyte Stimulating Hormone (MSH), human (Beta-MSH (1-22) (human))  Chemical Structure
  13. GC31573 β3-AR agonist 2 β3-AR agonist 2  Chemical Structure
  14. GC34231 γ-1-Melanocyte Stimulating Hormone (MSH), amide γ-1-Melanocyte Stimulating Hormone (MSH), amide  Chemical Structure
  15. GC17413 (±)-5'-Chloro-5'-deoxy-ENBA adenosine A1 receptor agonist, selective and high-affinity (±)-5'-Chloro-5'-deoxy-ENBA  Chemical Structure
  16. GC17408 (±)-AC 7954 hydrochloride urotensin-II (UT) receptor agonist (±)-AC 7954 hydrochloride  Chemical Structure
  17. GC15045 (±)-AMG 487 CXCR3 antagonist (±)-AMG 487  Chemical Structure
  18. GC41668 (±)-Clopidogrel (hydrochloride) Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). (±)-Clopidogrel (hydrochloride)  Chemical Structure
  19. GC16838 (±)-Cloprostenol sodium salt

    prostaglandin F2α (PGF2α) analog,FP receptor agonist

    (±)-Cloprostenol sodium salt  Chemical Structure
  20. GC18090 (±)-J 113397 NOP receptor antagonist (±)-J 113397  Chemical Structure
  21. GC62727 (±)-Penbutolol-d9 hydrochloride (±)-Penbutolol-d9 hydrochloride  Chemical Structure
  22. GC15144 (±)-PPCC oxalate sigma (σ) receptor ligand (±)-PPCC oxalate  Chemical Structure
  23. GC10907 (±)-SLV 319 CB1 receptor antagonist,potent and selective (±)-SLV 319  Chemical Structure
  24. GC12394 (±)-trans-ACPD

    metabotropic glutamate receptors agonist

    (±)-trans-ACPD  Chemical Structure
  25. GC32523 (±)-Befunolol (±)-Befunolol  Chemical Structure
  26. GC34957 (+)-Cevimeline hydrochloride hemihydrate (+)-Cevimeline hydrochloride hemihydrate  Chemical Structure
  27. GC30743 (+)-Cloprostenol (D-Cloprostenol) (+)-Cloprostenol (D-Cloprostenol)  Chemical Structure
  28. GC45259 (+)-Cloprostenol (sodium salt) (+)-Cloprostenol (sodium salt) is a more water soluble, crystalline form of (+)-cloprostenol. (+)-Cloprostenol (sodium salt)  Chemical Structure
  29. GC12750 (+)-Fluprostenol Prostaglandin F2α (FP) receptor agonist (+)-Fluprostenol  Chemical Structure
  30. GC18146 (+)-Igmesine hydrochloride σ1 receptor ligand (+)-Igmesine hydrochloride  Chemical Structure
  31. GC31597 (+)-Penbutolol ((R)-Penbutolol) (+)-Penbutolol ((R)-Penbutolol)  Chemical Structure
  32. GC17301 (+)-SK&F 10047 hydrochloride prototypical σ1 receptor agonist (+)-SK&F 10047 hydrochloride  Chemical Structure
  33. GC10675 (+,-)-Octopamine HCl adrenoceptor agonist (+,-)-Octopamine HCl  Chemical Structure
  34. GC50245 (+/-)-ADX 71743 Negative allosteric modulator of mGlu7 receptors; brain penetrant (+/-)-ADX 71743  Chemical Structure
  35. GC50048 (+/-)-PPCC oxalate Selective sigma (σ) agonist (σ1> σ2) (+/-)-PPCC oxalate  Chemical Structure
  36. GC61646 (-)-Camphoric acid (-)-Camphoric acid  Chemical Structure
  37. GC16919 (1R,1'S,3'R/1R,1'R,3'S)-L-054,264 somatostatin sst2 receptor agonist (1R,1'S,3'R/1R,1'R,3'S)-L-054,264  Chemical Structure
  38. GC34963 (1R,2S)-VU0155041 (1R,2S)-VU0155041  Chemical Structure
  39. GC34965 (20S)-Protopanaxatriol (20S)-Protopanaxatriol  Chemical Structure
  40. GC38712 (2R,3R)-E1R (2R,3R)-E1R  Chemical Structure
  41. GC38713 (2R,3S)-E1R (2R,3S)-E1R  Chemical Structure
  42. GC38714 (2S,3S)-E1R (2S,3S)-E1R  Chemical Structure
  43. GC32644 (4E)-SUN9221 (4E)-SUN9221  Chemical Structure
  44. GA20063 (D-Ala²)-Gastric Inhibitory Polypeptide (human) GIP receptor agonist. (D-Ala²)-Gastric Inhibitory Polypeptide (human)  Chemical Structure
  45. GA20084 (Deamino-Cys¹,β-cyclohexyl-Ala⁴,Arg⁸)-Vasopressin Studies revealed that this specific vasopressin agonist exhibited a nanomolar affinity for V-1b receptors from various mammalian species (bovine, human, rat). It exhibited high V-1b/V-1a and V-1b/oxytocin selectivity for rat, human, and bovine receptors. Furthermore, it showed a high V-1b/V-2 specificity for both bovine and human vasopressin receptors. Therefore, d(Cha?)-AVP is a promising tool for research of V-1b receptor structure-function relationships. (Deamino-Cys¹,β-cyclohexyl-Ala⁴,Arg⁸)-Vasopressin  Chemical Structure
  46. GA20195 (Gly¹,Ser³·²²,Gln⁴·³⁴,Thr⁶,Arg¹⁹,Tyr²¹,Ala²³·³¹,Aib³²)-Pancreatic Polypeptide (human) This (Ala-Aib)-containing pancreatic peptide/neuropeptide Y chimera is a highly selective neuropeptide Y? receptor agonist. At this receptor this compound turned out to be 25-fold more potent than the derivative H-5084 (0.24 nM vs 6 nM) and three-fold more potent than the native ligand neuropeptide Y (H-6375) (0.24 nM vs 0.6 nM). This analog turned out to increase feeding approximately 2.5-fold more effective than neuropeptide Y. (Gly¹,Ser³·²²,Gln⁴·³⁴,Thr⁶,Arg¹⁹,Tyr²¹,Ala²³·³¹,Aib³²)-Pancreatic Polypeptide (human)  Chemical Structure
  47. GA20221 (Hyp³)-Bradykinin Bradykinin antagonist. (Hyp³)-Bradykinin  Chemical Structure
  48. GA20229 (Leu³¹,Pro³⁴)-Neuropeptide Y (human, rat) Specific Y? receptor agonist. (Leu³¹,Pro³⁴)-Neuropeptide Y (human, rat)  Chemical Structure
  49. GC11952 (R)-(+)-Atenolol less active enantiomer of the racemic β1-adrenergic receptor antagonist, (R,S)-atenolol. (R)-(+)-Atenolol  Chemical Structure
  50. GC10608 (R)-(+)-Propranolol hydrochloride

    β-adrenoceptor antagonist

    (R)-(+)-Propranolol hydrochloride  Chemical Structure
  51. GC11219 (R)-(+)-Tolterodine Muscarinic receptor antagonists (R)-(+)-Tolterodine  Chemical Structure
  52. GC12144 (R)-(-)-Niguldipine hydrochloride L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist (R)-(-)-Niguldipine hydrochloride  Chemical Structure
  53. GC34985 (R)-ADX-47273 (R)-ADX-47273  Chemical Structure
  54. GC60001 (R)-Carvedilol (R)-Carvedilol  Chemical Structure
  55. GC10028 (R)-SLV 319 CB1 receptor antagonist (R)-SLV 319  Chemical Structure
  56. GC39298 (R)-Terazosin (R)-Terazosin  Chemical Structure
  57. GC50426 (R)-ZINC 3573 MRGPRX2 agonist (R)-ZINC 3573  Chemical Structure
  58. GC62588 (R,R)-CXCR2-IN-2 (R,R)-CXCR2-IN-2  Chemical Structure
  59. GC34995 (R,R)-Palonosetron Hydrochloride (R,R)-Palonosetron Hydrochloride  Chemical Structure
  60. GC12823 (R,S)-Atenolol β1-adrenergic receptor antagonist (R,S)-Atenolol  Chemical Structure
  61. GC63452 (Rac)-5-Hydroxymethyl Tolterodine (Rac)-5-Hydroxymethyl Tolterodine  Chemical Structure
  62. GC19541 (rac)-Antineoplaston A10

    (rac)-Antineoplaston A10 is the racemate of Antineoplaston A10

    (rac)-Antineoplaston A10  Chemical Structure
  63. GC62642 (rac)-Dobutamine-d6 hydrochloride (rac)-Dobutamine-d6 hydrochloride  Chemical Structure
  64. GC38721 (Rac)-E1R (Rac)-E1R  Chemical Structure
  65. GC63410 (Rac)-MRI-1867 (Rac)-MRI-1867  Chemical Structure
  66. GC62228 (rac)-Nebivolol-d4 (rac)-Nebivolol-d4  Chemical Structure
  67. GC34367 (RS)-Butyryltimolol (RS)-Butyryltimolol  Chemical Structure
  68. GC12279 (RS)-MCPG mGluR antagonist (RS)-MCPG  Chemical Structure
  69. GC15292 (S)-(+)-Niguldipine hydrochloride L-type Ca2+ channel blocker and α1A-adrenoceptor antagonist (S)-(+)-Niguldipine hydrochloride  Chemical Structure
  70. GC12463 (S)-(-)-Atenolol

    β-adrenergic blocker

    (S)-(-)-Atenolol  Chemical Structure
  71. GC15039 (S)-(-)-Pindolol beta-adrenergic antagonist (S)-(-)-Pindolol  Chemical Structure
  72. GC16637 (S)-(-)-Propranolol hydrochloride β-adrenoceptor antagonist (S)-(-)-Propranolol hydrochloride  Chemical Structure
  73. GC60006 (S)-Carvedilol (S)-Carvedilol  Chemical Structure
  74. GC35002 (S)-Mapracorat (S)-Mapracorat  Chemical Structure
  75. GC16349 (S)-MCPG mGluR antagonist (S)-MCPG  Chemical Structure
  76. GC10753 (S)-SLV 319 CB1 receptor antagonist (S)-SLV 319  Chemical Structure
  77. GC39249 (S)-Terazosin (S)-Terazosin  Chemical Structure
  78. GC60425 (S)-Verapamil D7 hydrochloride (S)-Verapamil D7 hydrochloride  Chemical Structure
  79. GC60008 (S)-Verapamil hydrochloride (S)-Verapamil hydrochloride  Chemical Structure
  80. GA20291 (Sar¹)-Angiotensin II The substitution with Sar at position 1 of angiotensin II resulted in a partial agonistic activity. (Sar¹)-Angiotensin II  Chemical Structure
  81. GC35011 (Z)-Thiothixene (Z)-Thiothixene  Chemical Structure
  82. GC16663 (±)-4-hydroxy Propranolol (hydrochloride) β1- and β2-adrenergic receptors inhibitor (±)-4-hydroxy Propranolol (hydrochloride)  Chemical Structure
  83. GC15087 (±)-Talinolol β1-selective adrenoceptor antagonist (±)-Talinolol  Chemical Structure
  84. GC15528 (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane PAF receptor antagonist (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane  Chemical Structure
  85. GC10600 1,3-Dipropyl-8-phenylxanthine A1 adenosine antagonist 1,3-Dipropyl-8-phenylxanthine  Chemical Structure
  86. GC12587 1-(1-Naphthyl) piperazine (hydrochloride) ligand for 5-HT receptors 1-(1-Naphthyl) piperazine (hydrochloride)  Chemical Structure
  87. GC17913 1-Deazaadenosine adenosine deaminase inhibitor 1-Deazaadenosine  Chemical Structure
  88. GC14607 1-Methylpsilocin 5-HT2C agonist,potent and selective 1-Methylpsilocin  Chemical Structure
  89. GC42011 1-Oleoyl Lysophosphatidic Acid A potent LPA receptor agonist 1-Oleoyl Lysophosphatidic Acid  Chemical Structure
  90. GC15140 1-Oleoyl lysophosphatidic acid sodium salt

    Activates LPA receptor

    1-Oleoyl lysophosphatidic acid sodium salt  Chemical Structure
  91. GC16876 1-Phenylbiguanide hydrochloride 5-HT3 receptor agonist 1-Phenylbiguanide hydrochloride  Chemical Structure
  92. GC10821 11-keto-β-Boswellic Acid leukotriene synthesis inhibitor via 5-lipoxygenase 11-keto-β-Boswellic Acid  Chemical Structure
  93. GC41883 12(S)-HHTrE 12(S)-HHTrE is a product of the cyclooxygenase (COX) pathway and one of the primary arachidonic acid metabolites of human platelets. 12(S)-HHTrE  Chemical Structure
  94. GC16693 13Z,16Z-Docosadienoic Acid FFAR4(GPR120) agonist 13Z,16Z-Docosadienoic Acid  Chemical Structure
  95. GC11133 16,16-Dimethyl Prostaglandin E2 derivative of prostaglandin E2 16,16-Dimethyl Prostaglandin E2  Chemical Structure
  96. GC32770 1A-116 1A-116  Chemical Structure
  97. GC17757 1H-1-ethyl Candesartan Cilexetil selective angiotensin II type 1 receptor (AT1) antagonist 1H-1-ethyl Candesartan Cilexetil  Chemical Structure
  98. GC11112 2'-MeCCPA A1 adenosine receptor agonist 2'-MeCCPA  Chemical Structure
  99. GC30561 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide  Chemical Structure
  100. GC16403 2-Arachidonoyl Glycerol An endogenous agonist of the cannabinoid (CB) receptors CB1 and CB2 2-Arachidonoyl Glycerol  Chemical Structure
  101. GC10116 2-chloro-3-Deazaadenosine adenosine receptors agonist 2-chloro-3-Deazaadenosine  Chemical Structure

Items 1 to 100 of 2711 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction